18. In Vivo Expansion of a Recipient Population of Cell Carriers Allows for Highly Effective Systemic Delivery of Oncolytic Reovirus Even in the Presence of Neutralizing Antibody

Molecular Therapy - United States

doi 10.1016/s1525-0016(16)34353-2